Aikaterini Thanou to Lupus Erythematosus, Systemic
This is a "connection" page, showing publications Aikaterini Thanou has written about Lupus Erythematosus, Systemic.
Connection Strength
2.651
-
Clinical disease activity and flare in SLE: Current concepts and novel biomarkers. J Autoimmun. 2021 05; 119:102615.
Score: 0.441
-
SARS-CoV-2 and Systemic Lupus Erythematosus. Curr Rheumatol Rep. 2021 01 28; 23(2):8.
Score: 0.439
-
New Trials in Lupus and where Are we Going. Curr Rheumatol Rep. 2018 05 03; 20(6):34.
Score: 0.363
-
Impact of heart rate variability, a marker for cardiac health, on lupus disease activity. Arthritis Res Ther. 2016 09 02; 18:197.
Score: 0.323
-
How should lupus flares be measured? Deconstruction of the safety of estrogen in lupus erythematosus national assessment-systemic lupus erythematosus disease activity index flare index. Rheumatology (Oxford). 2014 Dec; 53(12):2175-81.
Score: 0.274
-
Treatment of systemic lupus erythematosus: new therapeutic avenues and blind alleys. Nat Rev Rheumatol. 2014 Jan; 10(1):23-34.
Score: 0.264
-
Top 10 things to know about lupus activity measures. Curr Rheumatol Rep. 2013 Jun; 15(6):334.
Score: 0.258
-
Lupus patient decisions about clinical trial participation: a qualitative evaluation of perceptions, facilitators and barriers. Lupus Sci Med. 2020; 7(1):e000360.
Score: 0.103
-
IFN-a kinoid in systemic lupus erythematosus: results from a phase IIb, randomised, placebo-controlled study. Ann Rheum Dis. 2020 03; 79(3):347-355.
Score: 0.102
-
The Biomarkers of Lupus Disease Study: A Bold Approach May Mitigate Interference of Background Immunosuppressants in Clinical Trials. Arthritis Rheumatol. 2017 06; 69(6):1257-1266.
Score: 0.085